Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31
2019 · Journal of Clinical Oncology · 78 citations
https://doi.org/10.1200/jco.19.00443